Table 2.

Underlying malignancies and coexisting diseases of the overall study cohort.

Underlying malignancies and coexisting diseases		Total = 170 n (%)
Underlying malignancies	Hematologic malignancy	93 (54.7%)
	Solid organ tumour	58 (34.1%)
	Multiple myeloma	7 (4.1%)
	Acute myeloid leukaemia	51 (30%)
	Acute lymphocytic leukaemia	11 (6.4%)
	Chronic leukaemia	8 (4.7%)
	Lymphoma	11 (6.4%)
	Myelodysplastic syndrome	6 (3.5%)
	Other haematological malignity	8 (4.7%)
	Neutrophils < 100	38 (22.3%)
	Treatment duration (days)	16.1 ± 16.3
Coexisting diseases	Any coexisting disease	105 (61.8%)
	None	65 (38.2%)
	Diabetes mellitus	35 (20.6%)
	Chronic renal failure	7 (4.1%)
	Chronic obstructive lung disease	13 (7.6%)